MedTrace Logo

Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care

NCT01639586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2023-03-22

No results posted yet for this study

Summary

One of the interests of the Alzheimer Plan 2008-2010 is to provide increase support to helping families. It's also of major to involve the patient in the most active treatment possible, encouraging social inter relationship as well as cognitive and behavioural stimulation activities.

In the frame of non drug related approaches to Alzheimer disease (AD), several research projects and actions have already been conducted, but no specific study concerning the efficiency of different types of respite care structures have been conducted so far in France. The present project concerns the thematic of the frame "Development and diversification of respite care structures".

A platform is defined in the Alzheimer Plan as a "diversified range of despite structures according to patients' needs and informal caregivers' expectations" providing several objectives:

Two objectives targeting the informal caregivers:

* offer spare time or tutored
* inform, support and accompany

Two objectives targeting the patients:

* encourage maintain of the patient social life and relationships and work together towards his/her psychological and emotional well-being
* contribute to improve functional cognitive and sensory capacities

The study COMPARSE suggests to compare for the patient - informal caregiver couple, the impact of three different groups of patient care on health profit; resit platform (P), the day care group (D), the control group without access to a respite structure (C).

Conditions

  • Alzheimer Disease

Interventions

BEHAVIORAL

respite platform

Impact of the respite platform patient care on health profit

BEHAVIORAL

Day care

Impact of the day care on health profit of patient

BEHAVIORAL

No access to a respite structure

Control group without access to a respite structure

Sponsors & Collaborators

  • Department of Clinical Research and Innovation

    lead OTHER

Principal Investigators

  • Christian Pradier, PHD MD · Département de Santé Publique - CHU de Nice

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-10-31
Completion
2013-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639586 on ClinicalTrials.gov